FDA Inspection 1007275 — Dr. Paul R. Lambert
The FDA completed an inspection of Dr. Paul R. Lambert on April 5, 2017 in Charleston, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 5, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Charleston, SC (United States)
Additional Details
Clinical Investigator (CI)